跳至主要内容
临床试验/CTRI/2009/091/001025
CTRI/2009/091/001025已完成3 期

A Comparative, Randomized, Double Blind, Multicentric, Prospective Clinical Study to Evaluate the Efficacy, Safety and Tolerability of Naftifine Hydrochloride 1% cream Vs. Terbinafine Hydrochloride 1% cream in patients with Tinea pedis and Tinea cruris.

Ajanta Pharma Limited0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Males and female patients with age 18 to 70 years.
  • 2. Clinical diagnosis of Tinea pedis and Tinea cruris confirmed by laboratory evaluation (microscopic examination confirmed by a positive potassium hydroxide test).
  • 3. Written informed consent by patient.
  • 4. Patient willing to follow up.

排除标准

  • 1. Pregnant or nursing females.
  • 2. Patients suffering from onchomycosis, candidiasis, pityriasis versicolor or tinea capitis.
  • 3. Patients with severe chronic diseases.
  • 4. Hypersensitivity to components of Niftifine such as benzyl alcohol,cetyl alcohol ,cetyl esters wax,isopropyl myristate,polysorbat 60,sodium hydroxide,sorbitan monostearate etc.
  • 5. Patients who might have required concomitant medication with other antimycotics administered by another route.

研究者

相似试验